Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01978574
Other study ID # NMSS-PP1854
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 1, 2013
Est. completion date June 1, 2014

Study information

Verified date February 2020
Source Kessler Foundation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cognitive problems are a primary concern for people with multiple sclerosis. In many cases, people with MS report these issues to be more debilitating than the motor symptoms that are targeted by most treatment strategies. For people with MS, impaired memory and thinking skills can interfere with the ability to function efficiently in multiple professional and personal roles. Finding ways to decrease, slow, or reverse declines in memory and thinking skills is a vitally important research priority. We now know that engaging in intellectually enriching activities helps protect against the negative impact of MS disease-related declines in memory and thinking. Such activities contribute to something called 'cognitive reserve,' which serves as a protection against disease-related declines in memory and thinking. Thus far, no one has created a treatment that aims to provide a concentrated 'dose' of intellectual enrichment to build cognitive reserve. The present intervention aims to do precisely this. Here, we have developed a program of enriching activities that are delivered via a personal iPad. This allows for a 12-week 'treatment' that is entirely home-based, while also providing close personal contact between participants and our study personnel, who will communicate daily via emails. Week by week, participants choose from a menu of intellectually enriching activities such that their treatment is dynamic and customizable to fit their interests. The intervention is designed to be fun, as we hope the activities will be incorporated into people's lives beyond the period of the study itself. Given what we already know about the striking benefits of cognitive reserve to protect against disease-related declines in cognitive functioning, we expect to show that treatment with a daily, intense, intellectually enriching schedule of activities results in improved thinking and memory for people with MS. We will also investigate the positive impact of our treatment on the brains of people with MS through brain scans. We expect to see evidence for a shift toward more efficient processing in the brain, changes that translate to improved memory and thinking skills.


Recruitment information / eligibility

Status Completed
Enrollment 9
Est. completion date June 1, 2014
Est. primary completion date June 1, 2014
Accepts healthy volunteers No
Gender All
Age group 25 Years to 65 Years
Eligibility Inclusion Criteria:

- age 25-65

- MS duration >5 years

- read and speak English fluently

Exclusion Criteria:

- currently experiencing an MS exacerbation

- MS exacerbation within 6 weeks of study start

- left handed

- non-MRI compatible: metal in body, claustrophobic

- history of neurological disorder other than MS

- history of head injury

- history of schizophrenia or bipolar disorder

- pregnant

- currently taking steroids, benzodiazepines, and/or neuroleptics

- do not speak English as primary language

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Intellectual Enrichment daily activities
A daily program of intellectually enriching, iPad/tablet-based activities: games, reading/writing, hobby activities, or a documentary video (control).
Intellectual Enrichment documentary videos
Participants watch daily documentary videos.

Locations

Country Name City State
United States Kessler Foundation West Orange New Jersey

Sponsors (2)

Lead Sponsor Collaborator
Kessler Foundation National Multiple Sclerosis Society

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Change from Baseline in fMRI task-related BOLD activation pattern A neural pattern of fMRI BOLD activation indicating cerebral efficiency will be assessed at baseline and follow-up. Baseline and 13 weeks
Other Change from Baseline in fMRI-derived functional connectivity A neural pattern of fMRI functional connectivity will be assessed at baseline and follow-up. Baseline and 13 weeks
Primary Change from Baseline in Hopkins Verbal Learning Test and Brief Visuospatial Memory Test, Total Learning and Delayed Recall Baseline and 13 weeks
Secondary Change from Baseline in Beck Depression Inventory Baseline and 13 weeks